Drug Shortage Report for SANDOZ VALSARTAN HCT

Last updated on 2022-11-29 History
Report ID 174912
Drug Identification Number 02356724
Brand name SANDOZ VALSARTAN HCT
Common or Proper name VALSARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 12.5MG 320MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30FCT
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-09
Estimated end date 2022-12-09
Actual end date 2022-11-28
Shortage status Resolved
Updated date 2022-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-11-29 English Compare
v4 2022-11-28 French Compare
v3 2022-11-28 English Compare
v2 2022-11-16 French Compare
v1 2022-11-16 English Compare

Showing 1 to 5 of 5